Abortion advocates say court decisions are giving providers, patients "whiplash"
Abortion providers in Massachusetts are trying to work in a field with ever-changing rules.
Watch CBS News
Abortion providers in Massachusetts are trying to work in a field with ever-changing rules.
The Supreme Court on Thursday tossed out a challenge targeting the availability of a widely used abortion pill, preserving access to the drug.
Karen Lynch, CEO of CVS Health, discussed her company's decision to carry the abortion pill mifepristone, and cybersecurity threats in the wake of the UnitedHealth hack.
In January, the FDA changed regulations to allow retail pharmacies to sell the drug mifepristone.
The decision from the Supreme Court blocks lower court orders that would have restricted the availability of the abortion pill mifepristone nationwide.
Limits on how late into a pregnancy the drug can be taken, who can prescribe it and how it can be dispensed were set to take effect Saturday at 1 a.m.
The court maintained access to mifepristone for the time being but is only letting it be dispensed after a doctor's office visit, not by mail, and up to seven weeks into a pregnancy, not 10.